How can countries harness the potential of biosimilar medicines? A toolkit for policy-makers

This policy brief aims to summarize current knowledge on how the implementation of biosimilar policies could be optimized, based on current practice in 30 European countries. The successful implementation of biosimilar policies does not rely on a single action but requires a mix of supply-side and demand-side measures, implemented in a coherent manner at national, regional and local levels, as applicable.